Author

Boris D. Starostin

ORCID: 0009-0000-3286-1882

Observed ORCID: 0009-0000-3286-1882

OpenAlex ID: A5126254728

Real‐World Effectiveness and Safety of Saccharomyces boulardii CNCM I‐745 as Adjunct Therapy for Helicobacter pylori Eradication: Data From the European Registry on H. pylori Management (Hp‐ EuReg )

2026 · Olga P. Nyssen, Laimas Jonaitis, et al. · Helicobacter · 6

Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg)

2026 · Dmitry S. Bordin, Dmitrii N. Andreev, et al. · Antibiotics · 3

Lack of Usefulness of Literature‐Based Helicobacter pylori Resistance Data for Predicting First‐Line Empirical Treatment Effectiveness in the European Registry on H. pylori Management (Hp‐ EuReg )

2026 · Ismail Kirrout, Olga P. Nyssen, et al. · Helicobacter

Higher Doses of Bismuth and Antibiotics Do Not Improve Helicobacter pylori Treatment Effectiveness: Results From the European Registry on Helicobacter pylori Management

2026 · Samuel J. Martínez-Domínguez, Ángel Lanas, et al. · Clinical Gastroenterology and Hepatology

Rebamipide and its Use in Clinical Practice (Literature Review, Meta-Analysis and Our Experience), Part I. Preventive and Therapeutic Effect of Rebamipide in NSAID-Induced Gastroenteropathies

2026 · Boris D. Starostin

Works count: 5

Citation count: 9

H-index: 2

I10-index: